Navigation Links
Newly Published Study Shows Dramatic Reduction in Hospital Acquired Infections
Date:4/8/2011

NORTH TONAWANDA, N.Y., April 8, 2011 /PRNewswire/ -- VIGILAIR Systems, an industry leader in Ultraviolet Germicidal Irradiation (UVGI) technology was instrumental in a newly published, and first of its kind hospital study that demonstrated a dramatic reduction in patient Hospital Acquired Infections (HAI) with the application of VIGILAIR® air cleaning technology in a Neonatal Intensive Care Unit (NICU).

The published article 'Effect of enhanced ultraviolet germicidal irradiation in the heating ventilation and air conditioning system on ventilator associated pneumonia in a neonatal intensive care unit' appears in the April 2011 on-line edition of Journal of Perinatology (www.nature.com/jp). The study was conducted by Attending Physicians in the NICU of Women and Children's Hospital of Buffalo, located in Buffalo, NY, a University affiliated Regional Perinatal Center. This work was supported in part by a grant from the NYSTAR Center for Advanced Technology in Biomedical and Bioengineering by the Department of Pediatrics SUNY at Buffalo.

Results demonstrated a reduction of Ventilator Associated Pneumonia (VAP) by 50% in the most high risk population; NICU surface contamination reduction greater than 99.99%; Tracheal microbial colonization reduction by 45%; Antibiotic usage reduction by 62%; and an estimated annual clinical savings of greater than $500,000.

The air purification equipment, referred to as Enhanced Ultra Violet Germicidal Irradiation (e-UVGI), also known as a Pathogen Control System (PCS), was supplied by VIGILAIR Systems.

"This is, to our knowledge, the first published study of its kind," said Peter Bjorkman, President at VIGILAIR Systems, Inc. "The results show clearly how important the HVAC system is as a contamination source in sensitive environments like hospitals. The findings in this study correspond well with other studies VIGILAIR has been involved in at other hospitals," continued Bjorkman.

The company's PCS equipment is designed and manufactured for installation within existing hospital Heating Ventilation and Air Conditioning (HVAC) units. The PCS integrates standard UVGI emitters with MERV15 air filters in such a manner as to predictably destroy harmful viruses, bacteria and fungi at a pre-determined efficiency within a given HVAC's air-stream.

VIGILAIR Systems provides UVGI technology for HVAC surface and air disinfection, as well as sanitization systems for packaging material to the food and beverage industry.

The Department of Homeland Security has listed VIGILAIR's Biodefense (BD) System as Qualified Anti-terrorism Technology (QATT).

For information, visit www.vigilairsystems.com or call 716.692.8843.

MEDIA CONTACT:
Michele M. Bjorkman
VIGILAIR® Systems, Inc.
Office:  716-692-8843
Mobile: 716-830-9256


'/>"/>
SOURCE VIGILAIR Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™
2. Newly Integrated Software Suite From ZS Associates Offers Comprehensive Set of Sales Performance Management Software Solutions
3. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
4. Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing
5. Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment
6. First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
7. Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment
8. Hospira Supports Newly Introduced Biogenerics Legislation
9. febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment
10. Titanium and Aluminum Distributor, Trans World Alloys Relocates to Its Newly Built, State-of-the-Art Headquarters in Gardena, California
11. RBC Life Sciences Fills Newly Created Vice President of Sales and Marketing Position With Industry Veteran
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... 17, 2017 , ... Academy of Model Aeronautics (AMA), the ... of unmanned aircraft systems (UAS), are launching a joint program to promote safe ... support educational outreach efforts. , AMA and DJI will collaborate on other potential ...
(Date:2/16/2017)... MENLO PARK, Calif. and ... -- Longitude Capital, a private investment firm focused on ... today announced the promotion of Josh Richardson ... Richardson focuses on investments in biotechnology companies.  He ... and has played important roles in Longitude,s investments ...
(Date:2/16/2017)... 2017   Biostage, Inc. (Nasdaq: ... developing bioengineered organ implants to treat cancers and other ... today the closing on February 15, 2017 of its ... stock and warrants to purchase 20,000,000 shares of common ... offering was priced at $0.40 per share of common ...
(Date:2/16/2017)... Malden, MA (PRWEB) , ... February 16, 2017 ... ... viscoelastic 4-level cervical case. Dr. Kingsley Chin, professor and Harvard trained surgeon, completed ... The procedure was performed on a 55-year-old practicing female physician suffering from degenerative ...
Breaking Biology Technology:
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
(Date:2/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... the LEERINK Partners 6th Annual Global Healthcare Conference at ... 15, 2017 at 10 a.m. Eastern Time. ... accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will be ... Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
Breaking Biology News(10 mins):